Confusion about the strength of the antibacterial drug Zerbaxa could potentially lead to dosage errors, the Food and Drug Administration cautioned in a May 20 <a...

Field of Interest: Gastroentero...

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.